Hunan Hansen Pharmaceutical Co., Ltd. (002412.SZ)
Shenzhen - Shenzhen Delayed price. Currency in CNY
Add to watchlist
At close: 03:04PM CST
Currency in CNY
Valuation measures4
| Market cap (intra-day) | 2.89B |
| Enterprise value | 2.76B |
| Trailing P/E | 19.64 |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 3.15 |
| Price/book (mrq) | 1.55 |
| Enterprise value/revenue | 3.00 |
| Enterprise value/EBITDA | 16.53 |
Trading information
Stock price history
| Beta (5Y monthly) | N/A |
| 52-week change 3 | -13.40% |
| S&P500 52-week change 3 | 24.19% |
| 52-week high 3 | 7.38 |
| 52-week low 3 | 4.08 |
| 50-day moving average 3 | 5.33 |
| 200-day moving average 3 | 6.34 |
Share statistics
| Avg vol (3-month) 3 | 11.42M |
| Avg vol (10-day) 3 | 10.95M |
| Shares outstanding 5 | 503.2M |
| Implied shares outstanding 6 | 504.16M |
| Float 8 | 249.41M |
| % held by insiders 1 | 53.29% |
| % held by institutions 1 | 2.65% |
| Shares short 4 | N/A |
| Short ratio 4 | N/A |
| Short % of float 4 | N/A |
| Short % of shares outstanding 4 | N/A |
| Shares short (prior month ) 4 | N/A |
Dividends & splits
| Forward annual dividend rate 4 | 0.3 |
| Forward annual dividend yield 4 | 5.22% |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 102.49% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | 20 Jun 2023 |
| Last split factor 2 | 1.7:1 |
| Last split date 3 | 30 May 2019 |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Mar 2024 |
Profitability
| Profit margin | 21.70% |
| Operating margin (ttm) | 24.98% |
Management effectiveness
| Return on assets (ttm) | 5.03% |
| Return on equity (ttm) | 10.46% |
Income statement
| Revenue (ttm) | 959.39M |
| Revenue per share (ttm) | 1.91 |
| Quarterly revenue growth (yoy) | 1.50% |
| Gross profit (ttm) | N/A |
| EBITDA | 242.2M |
| Net income avi to common (ttm) | 208.21M |
| Diluted EPS (ttm) | 0.29 |
| Quarterly earnings growth (yoy) | 5.80% |
Balance sheet
| Total cash (mrq) | 273.82M |
| Total cash per share (mrq) | 0.54 |
| Total debt (mrq) | 95.12M |
| Total debt/equity (mrq) | 4.69% |
| Current ratio (mrq) | 2.77 |
| Book value per share (mrq) | 4.03 |
Cash flow statement
| Operating cash flow (ttm) | 111M |
| Levered free cash flow (ttm) | 39.45M |
© 2024 Yahoo. All rights reserved.